Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154874 | SCV000204556 | likely benign | not specified | 2014-10-24 | criteria provided, single submitter | clinical testing | p.Val31606Ile in exon 307 of TTN: This variant is not expected to have clinical significance due to a lack of evolutionary conservation. Of note, 4 mammals (gib bon, opossum, Tasmanian devil, and platypus) as well as several reptiles and fro g have an isoleucine (Ile) at this position despite high nearby amino acid conse rvation. It has also been identified in 1/8290 European American chromosomes and in 3/3904 African American chromosomes by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS/; dbSNP rs200430493). |
Genetic Services Laboratory, |
RCV000154874 | SCV000249291 | uncertain significance | not specified | 2014-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000554691 | SCV000642519 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-16 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000732023 | SCV000859899 | uncertain significance | not provided | 2018-02-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000732023 | SCV000978109 | likely benign | not provided | 2021-05-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390348 | SCV002670767 | likely benign | Cardiovascular phenotype | 2019-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |